These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15653133)

  • 21. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.
    Krishnaiah YS; Rama B; Raghumurthy V; Ramanamurthy KV; Satyanarayana V
    Pharm Dev Technol; 2009; 14(1):50-61. PubMed ID: 18819031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
    Kaur K; Kim K
    Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled drug delivery through tailor-made blend polymeric membranes.
    Stamatialis DF; Rolevink HH; Balster J; Koops GH
    J Control Release; 2005 Jan; 101(1-3):302-4. PubMed ID: 15678611
    [No Abstract]   [Full Text] [Related]  

  • 25. Polyhydroxyethylaspartamide-based micelles for ocular drug delivery.
    Civiale C; Licciardi M; Cavallaro G; Giammona G; Mazzone MG
    Int J Pharm; 2009 Aug; 378(1-2):177-86. PubMed ID: 19465101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flurbiprofen release from Eudragit RS and RL aqueous nanosuspensions: a kinetic study by DSC and dialysis experiments.
    Castelli F; Messina C; Sarpietro MG; Pignatello R; Puglisi G
    AAPS PharmSciTech; 2002; 3(2):E9. PubMed ID: 12916946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on preparation and properties of moisture permeable polyurethane membrane used for dressings].
    Huang Z; Li B; Hu Y; Yin G; Zheng C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Sep; 18(3):346-50. PubMed ID: 11605486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permeability studies in chitosan membranes. Effects of crosslinking and poly(ethylene oxide) addition.
    Neto CG; Dantas TN; Fonseca JL; Pereira MR
    Carbohydr Res; 2005 Dec; 340(17):2630-6. PubMed ID: 16202398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical compatibility of PU/PAN interpenetrating polymer network membrane with substituted aromatic solvents.
    Kumar H; Siddaramaiah
    J Hazard Mater; 2007 Sep; 148(1-2):467-76. PubMed ID: 17418943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and separation efficiencies of PPSU/PEI/PEG blend membranes with different compositions for water treatment.
    Hwang LL; Wey MY; Chen JC
    Water Sci Technol; 2012; 66(12):2712-21. PubMed ID: 23109590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal permeation of selegiline from hydrogel-membrane drug delivery systems.
    Fang JY; Hung CF; Chi CH; Chen CC
    Int J Pharm; 2009 Oct; 380(1-2):33-9. PubMed ID: 19563870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles.
    Ubrich N; Schmidt C; Bodmeier R; Hoffman M; Maincent P
    Int J Pharm; 2005 Jan; 288(1):169-75. PubMed ID: 15607269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices.
    Azarmi S; Ghaffari F; Löbenberg R; Nokhodchi A
    Farmaco; 2005; 60(11-12):925-30. PubMed ID: 16223498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ethylene-co-methyl acrylate) membranes as rate-controlling barriers for drug delivery systems: characterization, mechanical properties and permeability.
    Kanis LA; Generoso M; Meier MM; Pires AT; Soldi V
    Eur J Pharm Biopharm; 2005 Aug; 60(3):383-90. PubMed ID: 15996579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alginate/polyethylene glycol blend fibers and their properties for drug controlled release.
    Wang Q; Zhang N; Hu X; Yang J; Du Y
    J Biomed Mater Res A; 2007 Jul; 82(1):122-8. PubMed ID: 17269140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel polymer blends for the preparation of membranes for biohybrid liver systems.
    Kostadinova A; Seifert B; Albrecht W; Malsch G; Groth T; Lendlein A; Altankov G
    J Biomater Sci Polym Ed; 2009; 20(5-6):821-39. PubMed ID: 19323892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of pH- and temperature-sensitive pullulan microspheres for controlled release of drugs.
    Fundueanu G; Constantin M; Ascenzi P
    Biomaterials; 2008 Jun; 29(18):2767-75. PubMed ID: 18396330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Injectable in situ forming depot systems: PEG-DAE as novel solvent for improved PLGA storage stability.
    Schoenhammer K; Petersen H; Guethlein F; Goepferich A
    Int J Pharm; 2009 Apr; 371(1-2):33-9. PubMed ID: 19135512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
    Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K
    Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.